Mervyn Samuel
Obstetrics & Gynecology · Columbus, OHNPI 1356388581
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 68 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 14.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $980 and has fallen 54.3% since, to $448 in 2025.
Across 68 payments — averaging $46.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Myovant Sciences Inc.$459
- Minerva Surgical, Inc$430
- Alkermes, Inc.$345
- Teva Pharmaceuticals USA, Inc.$344
- Tris Pharma Inc$225
- Axsome Therapeutics, Inc.$201
- plus $1K from 13 others
Across 24 payments — averaging $3701.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bayer$89K
What the payments were for
- Food & beverage$3,161100%
- Education$110%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Myovant Sciences Inc. | 17 | $459 |
| Minerva Surgical, Inc | 6 | $430 |
| Alkermes, Inc. | 3 | $345 |
| Teva Pharmaceuticals USA, Inc. | 3 | $344 |
| Tris Pharma Inc | 2 | $225 |
| Axsome Therapeutics, Inc. | 2 | $201 |
| Corcept Therapeutics | 2 | $194 |
| Indivior Inc. | 8 | $183 |
| Abbott | 1 | $165 |
| Orexo US, Inc. | 7 | $149 |
| Lupin Inc. | 2 | $146 |
| Redhill Biopharma Inc. | 1 | $104 |
| Novo Nordisk | 4 | $68 |
| USWM, LLC | 3 | $48 |
| Currax Pharmaceuticals LLC | 3 | $40 |
| AbbVie | 1 | $33 |
| Exeltis, USA Inc. | 1 | $13 |
| Therapeuticsmd, Inc. | 1 | $12 |
| AMAG Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$462
- MYFEMBREE$225
- Dyanavel XR$225
- Quillivant$225
- Quillichew ER$225
- AUSTEDO$220
- ALERE$165
- VIVITROL$155
- SUBLOCADE$126
- Austedo XR$124
- Auvelity$121
- SOLOSEC$121
- Korlym$108
- Talicia$104
- Zubsolv$100
How this compares
$3,172 in reported general payments places this provider in the 85th percentile of 1,376 obstetrics & gynecology providers in Ohio.
Other obstetrics & gynecology in Columbus
- Erin OlahColumbus$97K
- David PortmanColumbus$94K
- Anita SomaniColumbus$93K
- Andrew BokorColumbus$35K
- Steven BalaloskiColumbus$20K
- Milroy SamuelColumbus$17K
- Shivkamini SomasundaramColumbus$16K
- Rachel GilmanColumbus$11K
- Leah AdkinsColumbus$11K
- Samir AhujaMentor$430K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.